Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation
While psychedelics have a history of sparking creativity, the first modern study to investigate the potential of psilocybin to enhance the brain’s ability to unlock creativity and problem solving is underway at the University of Texas, Austin and groups like Center for MINDS is exploring this connection. The post Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation first appeared on Lucid News. The post Beyond FDA Approval: Psychedelics as Catalysts For Creativity and Innovation appeared first on Lucid News.
External link. We are not responsible for the content.
Read more ↗More From Lucid News
Authors of Largest Microdosing Study Suggest Benefits Limited To Dosing Day
Recent research surveying 1,435 microdosers suggests that microdosing’s duration of effect might be more like that of...
New RAND Report Shows Therapeutic Use Driving U.S. Views Towards Psychedelics
A new report from the RAND Corporation shows that nearly one-quarter of U.S. adults now support the legal use of psil...
Oregon’s Psilocybin Program: Industry Insiders Weigh In On Closures and the Future
Industry insiders weigh in on the growing pains of Oregon's regulated psilocybin program which has seen concerns rais...
Latest News
Navigating Colorado’s Regulated Psychedelic Model: Lessons From the Front Lines
Entering the legal, regulated model of psychedelic therapy was the last thing on my mind when I moved to Colorado. I ...
Trip Sitting Course off to a great start!
There's still time to join!
“I Swore Off Psychedelic Retreats. Now, I’m Hosting One.”
After years of chaotic retreat experiences, one writer returns to the industry to see if it has finally grown up. [.....
LSD, Music, and the Art of Listening
Oli Genn-Bash discusses how LSD uniquely enhances active listening, creativity, and musical insight, offering a more ...
The State of the Psychedelic Industry & Open Questions (Video)
In the third video of a three-part series, Psychedelic Alpha’s Josh Hardman takes a look at some broader open questio...